CLINICAL_TRIALS
trial_result
· 2018-10-01
Clinical Trial Update: Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis [Phase 4]
Summary
A Phase 4 open-label study of Acthar SQ Gel Injection in patients with active anterior uveitis was terminated with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Washington University School of Medicine | Conditions: Uveitis | Phase 4 | Status: TERMINATED | Results posted: 2018-10-01